Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2021 1
2022 2
2023 2
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Anakinra efficacy in COVID-19 pneumonia guided by soluble urokinase plasminogen activator receptor: Association with the inflammatory burden of the host.
Kyriazopoulou E, Akinosoglou K, Florou E, Kouriannidi E, Bogosian A, Tsachouridou O, Syrigos KN, Gatselis N, Milionis H, Papanikolaou IC, Sympardi S, Dafni M, Alevizou A, Amvrazi AV, Alexandrou E, Archontoulis K, Argyraki K, Alexiou Z, Georgiou Y, Gkogka D, Kyrailidi F, Kalyva V, Nikolopoulou T, Ioannou S, Bakakos P, Karathanassiou G, Koklanos K, Miletis DN, Tili AM, Vakkas L, Vila I, Panagopoulos P, Samarkos M, Chrysos G, Dalekos GN, Poulakou G, Metallidis S, Giamarellos-Bourboulis EJ. Kyriazopoulou E, et al. Among authors: dafni m. Int J Antimicrob Agents. 2025 Jan;65(1):107405. doi: 10.1016/j.ijantimicag.2024.107405. Epub 2024 Dec 6. Int J Antimicrob Agents. 2025. PMID: 39647797 Free article. Clinical Trial.
Response to Hermida.
Nasothimiou EG, Dafni M, Roussias LG, Stergiou GS. Nasothimiou EG, et al. Among authors: dafni m. Hypertens Res. 2013 May;36(5):473-5. doi: 10.1038/hr.2013.6. Epub 2013 Feb 21. Hypertens Res. 2013. PMID: 23425957 No abstract available.
Empowering cancer prevention with AI: unlocking new frontiers in prediction, diagnosis, and intervention.
Dafni MF, Shih M, Manoel AZ, Yousif MYE, Spathi S, Harshal C, Bhatt G, Chodnekar SY, Chune NS, Rasool W, Umar TP, Moustakas DC, Achkar R, Kumar H, Naz S, Acuña-Chavez LM, Evgenikos K, Gulraiz S, Ali ESM, Elaagib A, Uggh IHP. Dafni MF, et al. Cancer Causes Control. 2025 Apr;36(4):353-367. doi: 10.1007/s10552-024-01942-9. Epub 2024 Dec 13. Cancer Causes Control. 2025. PMID: 39672997 Review.
Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure.
Giamarellos-Bourboulis EJ, Poulakou G, de Nooijer A, Milionis H, Metallidis S, Ploumidis M, Grigoropoulou P, Rapti A, Segala FV, Balis E, Giannitsioti E, Rodari P, Kainis I, Alexiou Z, Focà E, Lucio B, Rovina N, Scorzolini L, Dafni M, Ioannou S, Tomelleri A, Dimakou K, Tzatzagou G, Chini M, Bassetti M, Trakatelli C, Tsoukalas G, Selmi C, Samaras C, Saridaki M, Pyrpasopoulou A, Kaldara E, Papanikolaou I, Argyraki A, Akinosoglou K, Koupetori M, Panagopoulos P, Dalekos GN, Netea MG. Giamarellos-Bourboulis EJ, et al. Among authors: dafni m. Cell Rep Med. 2022 Feb 25;3(3):100560. doi: 10.1016/j.xcrm.2022.100560. eCollection 2022 Mar 15. Cell Rep Med. 2022. PMID: 35474750 Free PMC article.
The use of Isoflavones as Lung Cancer Chemoprevention Agents and their Implications in Treatment through Radio Sensitization.
Athanasiou E, Papageorgiou S, Dafni MF, Kelesis I, Vasileiou M, Tatsiou T, Kouveloglou V, Kanatas P, Stouras I, Gatsis A, Agiassoti VT, Nasimpian P, Dafnoudis D, Degaita K, Verras GI, Alexiou A, Papadakis M, Kamal MA. Athanasiou E, et al. Among authors: dafni mf. Curr Med Chem. 2025;32(2):214-237. doi: 10.2174/0109298673278897231229121524. Curr Med Chem. 2025. PMID: 38369709 Review.
12 results